Strabismus Clinical Trial
Official title:
Vision in Children Born to Opioid-dependent Methadone-maintained Mothers
The investigators will re-investigate 150 children studied extensively in the past. 100 of these children were born to mothers prescribed methadone during their pregnancy because of opiate dependency, and 50 were comparison children who were not exposed to drugs. These children were investigated when they were newborn babies, and again when they were six months old, and a quarter of the drug-exposed babies had problems with their eyesight, whilst very few of the comparison children has eyesight problems. The investigators would like to see whether the eyesight problems are still present in the children now that they are older. Because they are older, more detailed testing can be undertaken which will help to understand how drug exposure in the womb may have affected their eyesight. The investigators will recruit new, comparison children to the study to match the number of comparison children with the number of drug-exposed children. The findings will be relevant and important when advising mothers on drug use - both prescribed and illicit - when they are pregnant.
Multiple researchers across the world over many decades have noted eyesight problems in
children born to mothers who use drugs during pregnancy. From our earlier work on this group
of children, we have detailed knowledge of which drugs each mother used, making this group of
children uniquely important for understanding the consequences of drug use during pregnancy.
Although methadone use in the UK is dropping as heroin misuse falls, there is currently an
international epidemic of babies being born to mothers using illicit or prescribed opioid
drugs (e.g. methadone, heroin, opiate-based painkillers). These babies may be at risk of the
same eyesight problems as this Scottish cohort. Knowing the longer-term consequences and
disseminating the findings to relevant international clinical groups could help to alleviate
the consequential damage, through better information for mothers and through better and
prompter management of affected children.
The study is planned to run for 2 years. It is anticipated that a maximum of 65 drug-exposed
children (out of the original 100) will attend, and will therefore aim to also investigate 65
comparison children, as many as possible of whom will belong to the original cohort of 50
comparison children.
Testing will take place in the Children's Clinical Research Facility (CRF), on the campus of
the Queen Elizabeth University Hospital and Royal Hospital for Children, Glasgow. A CRF
paediatric nurse will recruit, coordinate and administrate the study. They will manage the
child's progress through the assessment session, measure height, weight and head
circumference, document demographic, social and educational details from the child's carer,
and will apply two questionnaires to the carers. Eyesight tests will be done by a specialist
paediatric orthoptist, and will include acuity (the smallest letter correctly identified),
stereoacuity (perception of depth) and looking for squints or nystagmus (shaking or wobbling
of the eyes).
Highly specialised eye tests (eye movement recordings and visual evoked potentials) will also
be undertaken.
If any abnormalities are noted from these tests, the child will be given eyedrops to dilate
their pupils. All children will be seen by a paediatric ophthalmologist who will look at the
back of their eyes, and check whether they need glasses, or whether their glasses are
correct. A medical history will be taken. If any problems are noted during the visit (e.g.
visual, medical, social), the child will be referred to relevant services after discussion
with their carer.
The data will be added to the existing database for these children, and the test results
correlated with the results found at birth and at six months, and with the any known drug
exposure of each child.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03596138 -
Reliability and Reproducibility of Automated Angular Measurement in Strabismus
|
||
Completed |
NCT04432181 -
Comparison of Deviation Types Among Astigmatic Children With Or Without Amblyopia
|
||
Recruiting |
NCT03713268 -
Intraoperative OCT Guidance of Intraocular Surgery II
|
||
Recruiting |
NCT04770519 -
Genetic Studies of Strabismus, Nystagmus, and Associated Disorders
|
||
Completed |
NCT01512355 -
The Effect of Dexmedetomidine on Decreasing Emergence Agitation and Delirium in Pediatric Patients Undergoing Strabismus Surgery
|
N/A | |
Completed |
NCT00461656 -
Povidone-iodine Antisepsis for Strabismus Surgery
|
Phase 4 | |
Completed |
NCT00535938 -
MDs on Botox Utility (MOBILITY)
|
N/A | |
Completed |
NCT01109459 -
Multimodal Physician Intervention to Detect Amblyopia
|
N/A | |
Not yet recruiting |
NCT06035757 -
The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery
|
Phase 4 | |
Completed |
NCT01430247 -
Vision Screening for the Detection of Amblyopia
|
N/A | |
Recruiting |
NCT04416776 -
Validation of the Utility of Strabismus Intelligent Diagnostic System
|
||
Recruiting |
NCT04353960 -
The Alaska Oculocardiac Reflex Study
|
||
Terminated |
NCT02246556 -
Dichoptic Virtual Reality Therapy for Amblyopia in Adults
|
Phase 1 | |
Completed |
NCT01726842 -
Amblyopia and Strabismus Detection Using a Pediatric Vision Scanner
|
N/A | |
Completed |
NCT00001143 -
Development of the Eye Motor System During the First 7 Months of Life in Infants With and Without a Family History of Cross-Eye
|
N/A | |
Completed |
NCT04303832 -
Exercise Interventions of Eye Muscles Post Strabismus Surgery
|
N/A | |
Completed |
NCT03806270 -
Hydroxyzine Dihydrochloride Premedication is a Necessity for Strabismus Surgery
|
||
Recruiting |
NCT05425589 -
Adjustable Strabismus Surgery
|
N/A | |
Completed |
NCT00559234 -
Potential Research Participants for Future Studies of Inherited Eye Diseases
|
N/A | |
Completed |
NCT02570555 -
Strabismus Surgery and Driving Ability
|